Sufianov, A.,
Bessonova, M.,
Begliarzade, S.,
Kudriashov, V.,
Danilov, A.,
Ilyasova, T.,
Yaolou, W.,
Nafikova, R.,
Beylerli, O. (2023) for proteins, mainly include micro
RNAs,
long non-coding RNAs, and circular
RNAs, play a role in regulating
on
non-coding RNAs and involvement in the same biological processes can become a basis for a complex
transposable elements are key evolutionary sources of
long non-coding RNAs, circular
RNAs, micro
RNAs, proteins
Gareev, Ilgiz,
Encarnacion Ramirez, Manuel de Jesus,
Nurmukhametov, Renat,
Ivliev, Denis,
Shumadalova, Alina,
Ilyasova, Tatiana,
Beilerli, Aferin,
Wang, Chunlei (2023) biomarkers and therapeutic targets specifically tailored for glioma. In recent years,
long non-coding RNAsGareev, I,
Gileva, Y,
Dzidzaria, A,
Beylerli, O,
Pavlov, V,
Agaverdiev, M,
Mazorov, B,
Biganyakov, I,
Vardikyan, A,
Jin, M,
Ahmad, A (2021) protein. Only recently has it been discovered that a whole class of molecules called
non-coding RNAs (nc
RNAsGareev, Ilgiz,
Aamir, Ahmad,
Jiaqi, Wang,
Aferin, Beilerli,
Tatiana, Ilyasova,
Albert, Sufianov,
Ozal, Beylerli (2023) ),
long non-coding RNAs
(lnc
RNAs), and circular
RNAs (circ
RNAs). They are involved in a wide range
) and
long non-coding RNAs (lnc
RNAs), as key regulators in the pathogenesis of hypertension. These nc
RNAsGilyazova, Irina,
Gimalova, Galiya,
Nizamova, Aigul,
Nizamova, Aigul,
Ishbulatova, Ekaterina,
Pavlov, Valentin,
Khusnutdinova, Elza (2024) by sequences that do not
code for proteins, much attention has been paid to
non-coding RNAs (nc
RNAs an urgent problem of modern medical science and practice.
Long non-coding RNAs (lnc
RNAs)-based therapeutics
GAREEV, I.F.,
BEILERLI, O.A.,
ALIEV, G.M.,
PAVLOV, VALENTIN,
IZMAILOV, ADEL,
ZHANG, YIWEI,
LIANG, YANCHAO,
YANG, GUANG (2020) are still under study.
Long non-coding RNAs (lnc
RNAs) are
non-coding RNAs that typically have a length